http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2779963-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 1998-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed8e4d054e7e9e0d3a649d44c302e2af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2f90c3630fa118a74f4aad0a9f29a6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8f877d3c45777325d06ad5e65a574bf |
| publicationDate | 1999-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2779963-A1 |
| titleOfInvention | USE OF A COMPOUND HAVING AFFINITY FOR THE MITOCHONDRIAL RECEPTOR OF BENZODIAZEPINES IN CANCER THERAPY |
| abstract | The present invention relates in particular to a combination product comprising at least one compound having an affinity for the mitochondrial benzodiazepine receptor, and at least one agent inducing apoptosis for simultaneous use, separate or spread over time, intended for the treatment of Cancer. Another aspect of the present invention relates to the use of said compound and / or of said combination product for the manufacture of a medicament in particular intended to facilitate the induction of apoptosis. |
| priorityDate | 1998-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 522.